Direct-to-consumer virtual care company Hims & Hers is partnering with Novo Nordisk to allow Americans to access a bundled offering that includes the pharma giant's obesity drug Wegovy and a Hims & Hers membership starting at $599 per month.
Hims & Hers members will have direct access to NovoCare Pharmacy, an offering through Novo Nordisk that allows cash-paying individuals without...
Direct-to-consumer virtual care company Hims & Hers has acquired at-home lab testing facility Sigmund NJ LLC, also known as Trybe Labs.
Hims & Hers said the acquisition of the New Jersey-based testing facility will allow customers to take better control of their health and permit providers to access a range of data and biomarkers that may help identify risk of disease before it develops....
Direct-to-consumer virtual care company Hims & Hers is receiving backlash to its 60-second commercial dubbed "Sick of the System" that ran during the Super Bowl on Fox.
The ad states that "obesity is America's deadliest epidemic" and claims that "something is broken, and it's not our bodies; it's the system." It then says the $160 billion weight loss industry "feeds on our failure."
It says...
Direct-to-consumer virtual care company Hims & Hers Health reported a 77% year-over-year increase in revenue from $226.7 million in the third quarter of 2023 to $401.6 million in Q3 2024.
The San Francisco-based company reported a net income for the third quarter of $75.6 million compared to a net loss of $7.6 million in the same period last year. It attributes the net income in Q3 to a $60....
Direct-to-consumer virtual care company Hims & Hers Health reported a 52% year-over-year increase in revenue from $207.9 million in the second quarter of 2023 to $315.6 million in Q2 2024.
The San Francisco-based company reported a net income for the second quarter of $13.3 million compared to a net loss of $7.2 million in the same period last year.
Adjusted EBITDA was $39.3 million for Q2...
Direct-to-consumer virtual care company Hims & Hers is the latest digital health company to announce it will add GLP-1 medications to its offerings to assist users with weight-loss management.
The San Francisco-based company, which launched its weight-loss program in December, said users will now have access to generic and 503B compounded injectable medications and oral medication kits...
Direct-to-consumer virtual care company Hims & Hers Health reported a total of $246.6 million in revenue for Q4 compared to $167.2 million for the fourth quarter of 2022 and total year-over-year revenue in 2023 of $872.0 million compared to $526.9 million for 2022.
The San Francisco-based company reported a net income for the fourth quarter of $1.2 million compared to a net loss of $10.9...
Leaders in the digital health space relayed to MobiHealthNews what stood out to them in 2023 as the year draws to an end.
Many noted the meteoric rise of genAI in 2023 and expectations of growing adoption of the technology in 2024, emphasizing the importance of treading carefully as the tech is further implemented. Other stakeholders pinpointed bankruptcies and mergers and acquisitions as being...
Direct-to-consumer virtual care company Hims & Hers Health announced last week the launch of a new AI-enabled offering, MedMatch, which provides healthcare providers with anonymized data points generated from the company's customer database, aimed at helping mental health professionals identify suitable treatments for patients.
Dr. Patrick Carroll, chief medical officer at Hims & Hers,...
Direct-to-consumer virtual care company Hims & Hers Health reported 57% year-over-year revenue in the third quarter of this year at $226.7 million, compared to $144.8 million in the same period last year.
Net loss was $7.6 million in Q3 this year, down from $18.8 million in Q3 last year, and adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) was $12.3 million,...
